Navigation Links
KalVista Pharmaceuticals and JDRF Form Research Partnership Focused on Novel Approach for Treating Diabetic Eye Disease
Date:1/9/2012

SOUTHAMPTON, ENGLAND and NEW YORK, Jan. 9, 2012 /PRNewswire-USNewswire/ -- KalVista Pharmaceuticals ("KalVista") and JDRF have formed a research partnership focused on a novel approach being developed by KalVista to preserve vision and slow the progression of diabetic eye disease. Diabetic eye disease is one of the most common and most serious complications in people with type 1 diabetes (T1D). JDRF will provide up to $2.2 million in milestone-based financial support and research expertise to KalVista. The goal of this partnership is to advance KalVista's lead pre-clinical candidate, a plasma kallikrein inhibitor, into human proof-of-concept clinical trials and to generate clinical data that would highlight its potential as an entirely new approach to treat diabetic macular edema (DME). DME is a leading cause of visual loss for people with T1D that involves swelling of the retina, which can lead to blurred vision and blindness.

Plasma kallikrein is an enzyme (a serine protease) that has been identified as a potential therapeutic target in people with diabetic retinopathy. Research has shown   that it contributes to increases in blood vessel leakage and thickening of the retina. Previous JDRF-funded studies led by one of KalVista's co-founders, Edward Feener, Ph.D., Associate Professor of Medicine at Harvard Medical School and Joslin Diabetes Center, demonstrated that plasma kallikrein is increased and activated in the vitreous fluid of people with DME . This data suggests that chronic activation of plasma kallikrein increases blood vessel inflammation and permeability by generating the production of a hormone called bradykinin, which causes blood vessels to dilate or enlarge. Plasma kallikrein inhibitors are believed to reduce retinal vessel leakage by suppressing the chronic and excessive production of bradykinin.

"Diabetic eye disease is a high priority research area for JDRF. Our support of Dr. Feener's academic research over the years
'/>"/>

SOURCE JDRF
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. KalVista Pharmaceuticals Launched With £8 Million in Series A Funding to Develop Novel Class of Drugs for Diabetic Macular Edema
2. Questcor Pharmaceuticals Reports Strong Finish to 2011
3. Valeant Pharmaceuticals to Present at 30th Annual J.P. Morgan Healthcare Conference
4. Radient Pharmaceuticals Announces New Advertisement for Oncology Publications
5. Savient Pharmaceuticals Announces Permanent J-Code Assigned for KRYSTEXXA®
6. Endo Pharmaceuticals and BioDelivery Sciences International Sign Licensing Agreement for BEMA Buprenorphine
7. BioDelivery Sciences Announces Worldwide License and Development Agreement with Endo Pharmaceuticals for BEMA Buprenorphine
8. Savient Pharmaceuticals to Present at the Noble Financial Capital Markets Eighth Annual Equity Conference
9. Acella Pharmaceuticals, LLC Announces Its Acquisition of the PRENATE® Family of Trademarks and Associated Intellectual Property
10. Syndax Pharmaceuticals Signs Agreement with Ventana Medical Systems, Inc. to Develop Companion Diagnostic Test for Entinostat
11. Ampio Pharmaceuticals Schedules Webcast to Update Shareholders
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/29/2015)... DIEGO and BOSTON , ... leader in instrument development, custom automation, and contract manufacturing, ... of the Nanopatch™ needle-free drug delivery technology, have been ... development of the Nanopatch Jet Coating Instrument , ... delivery research and product development.  The award was announced ...
(Date:5/29/2015)... , May 29, 2015 /CNW/ - Covalon Technologies Ltd. ... medical technologies company, is delighted to announce its ... 31, 2015, which includes revenue for three months ... of $264,340. Revenue from advanced wound care product sales ... 2015 increased 24% to $1,742,672 compared to $1,400,065 ...
(Date:5/29/2015)... British Columbia and MENLO ... -- DelMar Pharmaceuticals, Inc. (OTCQX: DMPI) ... on developing and commercializing proven cancer therapies in ... at the American Association of Cancer Research ... on the potential for its lead product candidate ...
Breaking Medicine Technology:Invetech And Vaxxas Named Recipients Of The 2015 Good Design Award For Development Of Nanopatch Jet Coating Instrument For Needle-Free Drug Delivery 2Invetech And Vaxxas Named Recipients Of The 2015 Good Design Award For Development Of Nanopatch Jet Coating Instrument For Needle-Free Drug Delivery 3Covalon Announces Strong Second Quarter Results 2Covalon Announces Strong Second Quarter Results 3DelMar Pharmaceuticals Presents Additional Data on the Potential of VAL-083 in the Treatment of Temozolomide-Resistant Glioblastoma Multiforme 2DelMar Pharmaceuticals Presents Additional Data on the Potential of VAL-083 in the Treatment of Temozolomide-Resistant Glioblastoma Multiforme 3DelMar Pharmaceuticals Presents Additional Data on the Potential of VAL-083 in the Treatment of Temozolomide-Resistant Glioblastoma Multiforme 4DelMar Pharmaceuticals Presents Additional Data on the Potential of VAL-083 in the Treatment of Temozolomide-Resistant Glioblastoma Multiforme 5
... ALEXANDRIA, Va., April 16, 2012 Thirty years ... was passed, enabling tens of millions of Americans ... at life,s end from the nation,s dedicated hospice ... the most compassionate corps of trained volunteers seen ...
... PITTSBURGH, April 16, 2012  Mastech Holdings, Inc. (NYSE ... provider of Information Technology and Specialized Healthcare Staffing services, has scheduled ... first quarter ended March 31, 2012.  The conference ... at 9:00 a.m. Eastern Time and will be ...
Cached Medicine Technology:Thirty Years Since Medicare Hospice Legislation Recognized Value of Hospice Volunteers 2Mastech Holdings, Inc. to Discuss First Quarter 2012 Financial Results on April 25, 2012 2
(Date:5/29/2015)... 2015 Ready to hit the road? Before ... drivers to get their vehicles ready. With handicapped vehicles, there ... Driving Systems (ADS) is ready to help drivers get their ... summer road trips. , When planning for the big trip, ... that the trip goes smoothly and they are prepared for ...
(Date:5/29/2015)... Island (PRWEB) May 29, 2015 The ... 2015. The event, now closed to new registration, starts ... Adams. This exciting competitive running event demonstrates the ... to create a public benefit – in this case, ... coastal views around the famed Ocean Drive and passes ...
(Date:5/29/2015)... CA (PRWEB) May 29, 2015 The science ... in the last decade. New and more efficient methods of ... available to balding patients. One of the most cutting edge ... Mohebi Hair Restoration is the technique of extracting hair from ... scalp transplants are performed to correct male pattern baldness. ...
(Date:5/29/2015)... 2015 Red Hot & Blue Restaurants ... Hot & Blue restaurant at 525 New Waverly Place in ... 2015. “The Red Hot & Blue Restaurant was previously located ... we have moved to a new location in the center,” ... of all the activities on the Promenade–with outdoor seating and ...
(Date:5/29/2015)... (PRWEB) May 29, 2015 The ... the graduates of its Advanced Training Program (ATP) ... who fill roles in their health care organization ... theory and methodology of continuous quality improvement in ... sister-program to Dr. Brent James’ internationally recognized Advanced ...
Breaking Medicine News(10 mins):Health News:Advanced Driving Systems Offers Tips for Summer Road Trips 2Health News:Advanced Driving Systems Offers Tips for Summer Road Trips 3Health News:The Newport 10 Miler at Fort Adams, an Outstanding Example of Event Marketing Helping in Preservation, is Now Completely Booked for 2015 2Health News:The Newport 10 Miler at Fort Adams, an Outstanding Example of Event Marketing Helping in Preservation, is Now Completely Booked for 2015 3Health News:Beard to Scalp Hair Transplant: Newest Advance in Hair Transplant Technology 2Health News:Red Hot & Blue Restaurant Opens in Cary, North Carolina 2Health News:Red Hot & Blue Restaurant Opens in Cary, North Carolina 3Health News:Red Hot & Blue Restaurant Opens in Cary, North Carolina 4Health News:HORNE LLP’s Healthcare Delivery Institute Graduates Class from the Advanced Training Program 2
... Health Market Science,(HMS) has been named to Deloitte,s ... ranking of the 50 fastest growing technology,media, telecommunications ... & Touche USA LLP, one of the nation,s ... percentage revenue growth,over five years from 2002-2006. The ...
... Jack Group, Inc.,(MattsonJack) announces the release of its ... help clients make strategic,decisions based on an in-depth ... conditions. Comorbidity Database(TM) consists of,two modules: Comorbidity Database(TM) ... and Comorbidity Database(TM) -- Med 2.0, which features ...
... the Board of Governors Gene Therapeutics Research Institute at ... that it is possible to sustain therapeutic gene expression ... year, even in the presence of an anti-viral immune ... , The researchers demonstrated in an animal model that ...
... Therapeutics Inc.,("Transition") (NASDAQ: TTHI , TSX: TTH) ... half of the US$15 million upfront payment,under the ... Corporation, plc ("Elan") (NYSE: ELN ) for ... completed Phase I clinical trials and the drug,candidate ...
... One of the nation,s largest and most respected radiology ... with AMICAS to revolutionize radiology IT solutions, ... AMCS ),a leader in radiology and medical image and ... new enterprise agreement,with Radiology Ltd. of Tucson, AZ. ...
... 26 People with,diabetes who have asymptomatic heart disease ... to their hearts without surgical intervention, according,to a study ... which,comes out on October 26, 2007., Researchers found ... aggressively treated their cardiac risk factors with,medication were able ...
Cached Medicine News:Health News:Health Market Science Ranked Number Ten in Deloitte's Technology Fast 50 Program for Greater Philadelphia 2Health News:Health Market Science Ranked Number Ten in Deloitte's Technology Fast 50 Program for Greater Philadelphia 3Health News:The Mattson Jack Group, Inc. Announces the Release of the New Comorbidity Database(TM) 2Health News:Transition Therapeutics Receives Remaining Upfront Payment from Elan Corporation, plc 2Health News:Radiology Ltd. Chooses AMICAS as End-to-End Solutions Provider 2Health News:Radiology Ltd. Chooses AMICAS as End-to-End Solutions Provider 3Health News:Aggressively Treating Cardiac Risk Factors May Reverse Ischemia 2
... are automated, easy to operate and maintain. ... environment by flexible snap-seal pockets which minimize ... contamination of the water. Offered in two-, ... also accommodate bags of various sizes. ThermoLine ...
... thawing systems are automated, easy to operate ... the outside environment by flexible snap-seal pockets ... or viral contamination of the water. Offered ... systems can also accommodate bags of various ...
Conventional Digitally-Controlled Water Baths...
Dry thaws. Has an ingenious (pat. pending) massaging sytem that utilizes the tempered bladders as hands. There are no unreliable mechanical parts involved. Two pumps pressurize different segments of ...
Medicine Products: